Table 1. Total number of prevalent cases, severity distribution and weighted-average disability weight by cancer type, Scotland, 2016.
| Cancer type | Number of prevalent cases | Proportion of prevalent cases in each phase/sequelae a, b | Weighted-average disability weight | |||
|---|---|---|---|---|---|---|
| Diagnosis and primary therapy phase | Controlled phase | Metastatic phase | Terminal phase | |||
| Brain and nervous system | 978 | 0.091 | 0.724 | 0.153 b | 0.032 b | 0.148 |
| Cervical | 2,343 | 0.056 a | 0.903 | 0.036 a | 0.005 a | 0.079 |
| Gallbladder and biliary tract | 359 | 0.114 a | 0.719 b | 0.123 a | 0.047 a | 0.148 |
| Hodgkin lymphoma | 1,202 | Data not available at sequelae level | 0.078 | |||
| Kidney | 4,592 | 0.078 a | 0.865 | 0.047 | 0.010 b | 0.091 |
| Lip and oral cavity | 2,970 | 0.062 a | 0.853 b | 0.075 a | 0.010 a | 0.099 |
| Liver | 927 | 0.124 a | 0.744 b | 0.086 a | 0.045 a | 0.136 |
| Malignant skin melanoma | 8,905 | 0.033 a | 0.941 | 0.023 | 0.003 a | 0.068 |
| Mesothelioma | 228 | 0.123 b | 0.408 a | 0.395 b | 0.075 b | 0.273 |
| Multiple myeloma | 1,971 | 0.105 b | 0.616 | 0.264 a | 0.015 a | 0.187 |
| Nasopharynx | 131 | Data not available at sequelae level | 0.107 | |||
| Non-Hodgkin’s lymphoma | 5,885 | 0.043 a | 0.902 | 0.048 a | 0.008 a | 0.082 |
| Oesophageal | 1,543 | 0.134 b | 0.669 b | 0.154 a | 0.043 a | 0.164 |
| Other pharynx | 1,155 | 0.078 a | 0.828 b | 0.081 a | 0.013 a | 0.107 |
| Ovarian | 2,715 | 0.033 a | 0.801 b | 0.154 a | 0.011 a | 0.125 |
| Pancreatic | 662 | 0.165 a | 0.600 b | 0.148 a | 0.088 a | 0.191 |
| Stomach | 1,343 | 0.110 a | 0.754 b | 0.102 a | 0.034 a | 0.133 |
| Testicular | 1,895 | Data not available at sequelae level | 0.061 | |||
| Thyroid | 1,811 | Data not available at sequelae level | 0.069 | |||
| Tracheal, bronchus, and lung | 7,642 | 0.090 b | 0.714 b | 0.149 a | 0.047 a | 0.153 |
| Uterine | 4,809 | 0.055 a | 0.886 | 0.054 b | 0.006 b | 0.086 |
The number of prevalent cases were supressed for all four sequelae if one or more of the sequelae had a value of 9 or less, as per the NHS National Services Scotland disclosure protocol. All data were retained for use in intermediate calculations of weighted-average disability weights.
Shaded cells within the table indicate that the Scottish severity proportion lies outside the GBD 2016 severity proportion 95% uncertainty interval (UI).
a Scottish severity proportion lies below the lower limit of the GBD 2016 severity proportion 95% UI.
b Scottish severity proportion lies above the upper limit of the GBD 2016 severity proportion 95% UI.